Barclays analyst Peter Lawson maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $105.00.

Barclays PLC lifted its holdings in shares of Regulus Therapeutics Inc. (NASDAQ:RGLS – Free Report) by 285.2% during the 3rd quarter, Holdings Channel reports. The firm owned 84,477 shares of the ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Like many people, I'm always on the hunt for the best place to stash my savings and grow my money faster. For a while now, the Barclays Tiered Savings account has been catching my eye with its offer ...

Recently appointed chief executive of Barclays Bank Ireland, Andrew Hastings, meets with the various arms of the bank’s operation. Across the a variety of departments from wealth management to its ...

There are more than 20 million Barclays customers in the UK (Picture: Bloomberg via Getty Images) On X, Alex Williams shared that he’d received a letter informing him his £3,000 overdraft ...

Tesla, the global leader in electric vehicles (EV) and renewable energy, is Musk's primary wealth generator. According to Bloomberg, Elon Musk owns approximately 13% of Tesla, citing the company’s ...

Barclays Plc is set to increase annual bonuses by as much as 20% in its investment bank after an improved year for traders and advisory teams. Staff in Barclays’s trading unit are expected to ...

Jay Inslee is proposing a novel tax on personal wealth above $100 million in hopes of plugging a budget shortfall and averting cuts to education, mental health services and police. The tax would apply ...

China’s billionaires are slowly starting to recover their wealth after three years of losses from a property crisis and Xi Jinping’s push for common prosperity at the expense of powerful ...